Loss of ARHGDIA expression is associated with poor prognosis in HCC and promotes invasion and metastasis of HCC cells

International Journal of Oncology

Volumn 45, Issue 2, 2014, Pages 659-666

  Liang, Lei ^a   Li, Qian ^b   Huang, Li Yong ^a   Li, Da Wei ^a   Wang, Yu Wei ^a   Li, Xin Xiang ^a   Cai, San Jun ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

ARHGDIA; Hepatocullular carcinoma; Metastasis; Recurrence; Rho GTP; Survival

Indexed keywords

RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 1; ARHGDIA PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER PROGNOSIS; CARCINOMA CELL; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS POTENTIAL; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RECURRENCE RISK; STAINING; TUMOR INVASION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; GENETIC TRANSDUCTION; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIVER TUMOR; METABOLISM; MORTALITY; MOUSE; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE; WESTERN BLOTTING; XENOGRAFT;

ADULT; ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR ALPHA; TRANSDUCTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84902587879     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2451     Document Type: Article

References (29)

1. Bosch FX, Ribes J, Díaz M and Cléries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology 127 (Suppl 1): S5-S16, 2004. (Pubitemid 39423365)
2. Portolani N, Coniglio A, Ghidoni S, et al: Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243: 229-235, 2006. (Pubitemid 43185442)
3. Bruix J, Boix L, Sala M and Llovet JM: Focus on hepatocellular carcinoma. Cancer Cell 5: 215-219, 2004. (Pubitemid 38402113)
4. Takai Y, Sasaki T and Matozaki T: Small GTP-binding proteins. Physiol Rev 81: 153-208, 2001. (Pubitemid 32098004)
5. Fukumoto Y, Kaibuchi K, Hori Y, et al: Molecular cloning and characterization of a novel type of regulatory protein (GDI) for the rho proteins, ras p21-like small GTP-binding proteins. Oncogene 5: 1321-1328, 1990.
6. Leonard D, Hart MJ, Platko JV, et al: The identification and characterization of a GDP-dissociation inhibitor (GDI) for the CDC42Hs protein. J Biol Chem 267: 22860-22868, 1992.
7. Sun HC, Zhang W, Qin LX, et al: Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. J Hepatol 47: 684-690, 2007. (Pubitemid 47503431)
8. Gao Q, Qiu SJ, Fan J, et al: Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25: 2586-2593, 2007. (Pubitemid 47041232)
9. Ellenbroek SI and Collard JG: Rho GTPases: functions and association with cancer. Clin Exp Metastasis 24: 657-672, 2007. (Pubitemid 50002983)
10. Harding MA and Theodorescu D: RhoGDI signaling provides targets for cancer therapy. Eur J Cancer 46: 1252-1259, 2010.
11. Jones MB, Krutzsch H, Shu H, et al: Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics 2: 76-84, 2002. (Pubitemid 34273101)
12. Zhao L, Wang H, Li J, Liu Y and Ding Y: Overexpression of Rho GDP-dissociation inhibitor α is associated with tumor progression and poor prognosis of colorectal cancer. J Proteome Res 7: 3994-4003, 2008.
13. Zhao L, Wang H, Sun X and Ding Y: Comparative proteomic analysis identifies proteins associated with the development and progression of colorectal carcinoma. FEBS J 277: 4195-4204, 2010.
14. Forget MA, Desrosiers RR, Del M, et al: The expression of rho proteins decreases with human brain tumor progression: potential tumor markers. Clin Exp Metastasis 19: 9-15, 2002. (Pubitemid 34208349)
15. Jiang WG, Watkins G, Lane J, Cunnick GH, Douglas-Jones A, Mokbel K and Mansel RE: Prognostic value of rho GTPases and rhoguanine nucleotide dissociation inhibitors in human breast cancers. Clin Cancer Res 9: 6432-6440, 2003. (Pubitemid 38031830)
16. Habets GG, Scholtes EH, Zuydgeest D, et al: Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 77: 537-549, 1994. (Pubitemid 24153994)
17. Hordijk PL, ten Klooster JP, van der Kammen RA, et al: Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science 278: 1464-1466, 1997. (Pubitemid 27509819)
18. Turner SJ, Zhuang S, Zhang T, et al: Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors. Biochem Pharmacol 75: 405-413, 2008. (Pubitemid 350298465)
19. Shibata S, Nagase M, Yoshida S, et al: Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med 14: 1370-1376, 2008.
20. Gorovoy M, Neamu R, Niu J, et al: RhoGDI-1 modulation of the activity of monomeric RhoGTPase RhoA regulates endothelial barrier function in mouse lungs. Circ Res 101: 50-58, 2007. (Pubitemid 47094623)
21. Wei L, Imanaka-Yoshida K, Wang L, et al: Inhibition of Rho family GTPases by Rho GDP dissociation inhibitor disrupts cardiac morphogenesis and inhibits cardiomyocyte proliferation. Development 129: 1705-1714, 2002. (Pubitemid 34874187)
22. Li XR, Ji F, Ouyang J, et al: Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma. Eur J Surg Oncol 32: 1130-1134, 2006. (Pubitemid 44774395)
23. Wang D, Dou K, Xiang H, et al: Involvement of RhoA in progression of human hepatocellular carcinoma. J Gastroenterol Hepatol 22: 1916-1920, 2007. (Pubitemid 47525048)
24. Fuku K, Tamura S, Wada A, et al: Expression and prognostic role of RhoA GTPases in hepatocellular carcinoma. J Cancer Res Clin Oncol 132: 627-633, 2006. (Pubitemid 44310328)
25. Wu X, Chen H, Gao Q, et al: Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma. Mol Carcinog 53: 325-336, 2014.
26. Takenawa T and Suetsugu S: The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nat Rev Mol Cell Biol 8: 37-48, 2007. (Pubitemid 46012013)
27. Lee TK, Man K, Ho JW, et al: Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target. Carcinogenesis 26: 681-687, 2005. (Pubitemid 41214160)
28. Liu S, Yu M, He Y, et al: Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology 47: 1964-1973, 2008. (Pubitemid 351945563)
29. Chen L, Chan TH, Yuan YF, et al: CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. J Clin Invest 120: 1178-1191, 2010.